FDA Drug Application (200063) for CONTRAVE by OREXIGEN

Back to FDA Applications sponsored by OREXIGEN

Application Number200063
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage90MG;8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCONTRAVE
Active IngredientBUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient BUPROPION HYDROCHLORIDE7
List of drugs with Active Ingredient NALTREXONE HYDROCHLORIDE5


Back to FDA Applications sponsored by OREXIGEN